ID   H2B2E_MOUSE             Reviewed;         126 AA.
AC   Q64524;
DT   11-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   07-NOV-2018, entry version 164.
DE   RecName: Full=Histone H2B type 2-E;
DE   AltName: Full=H2b 613;
GN   Name=Hist2h2be;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ES;
RX   PubMed=8858345; DOI=10.1101/gr.6.8.702;
RA   Wang Z.-F., Tisovec R., Debry R.W., Frey M.R., Matera A.G.,
RA   Marzluff W.F.;
RT   "Characterization of the 55-kb mouse histone gene cluster on
RT   chromosome 3.";
RL   Genome Res. 6:702-714(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12408966; DOI=10.1006/geno.2002.6850;
RA   Marzluff W.F., Gongidi P., Woods K.R., Jin J., Maltais L.J.;
RT   "The human and mouse replication-dependent histone genes.";
RL   Genomics 80:487-498(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD;
RC   TISSUE=Adrenal gland, Kidney, Liver, Lung, Muellerian duct, Ovary, and
RC   Urinary bladder;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (HIST2H2BE).
RC   TISSUE=Olfactory epithelium;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=15197225; DOI=10.1084/jem.20032247;
RA   Fernandez-Capetillo O., Allis C.D., Nussenzweig A.;
RT   "Phosphorylation of histone H2B at DNA double-strand breaks.";
RL   J. Exp. Med. 199:1671-1677(2004).
RN   [6]
RP   PHOSPHORYLATION AT SER-15.
RX   PubMed=16039583; DOI=10.1016/j.immuni.2005.05.007;
RA   Odegard V.H., Kim S.T., Anderson S.M., Shlomchik M.J., Schatz D.G.;
RT   "Histone modifications associated with somatic hypermutation.";
RL   Immunity 23:101-110(2005).
RN   [7]
RP   PHOSPHORYLATION AT SER-37.
RX   PubMed=20647423; DOI=10.1126/science.1191241;
RA   Bungard D., Fuerth B.J., Zeng P.Y., Faubert B., Maas N.L., Viollet B.,
RA   Carling D., Thompson C.B., Jones R.G., Berger S.L.;
RT   "Signaling kinase AMPK activates stress-promoted transcription via
RT   histone H2B phosphorylation.";
RL   Science 329:1201-1205(2010).
RN   [8]
RP   CROTONYLATION AT LYS-6; LYS-12; LYS-13; LYS-16; LYS-17; LYS-21; LYS-24
RP   AND LYS-35.
RX   PubMed=21925322; DOI=10.1016/j.cell.2011.08.008;
RA   Tan M., Luo H., Lee S., Jin F., Yang J.S., Montellier E., Buchou T.,
RA   Cheng Z., Rousseaux S., Rajagopal N., Lu Z., Ye Z., Zhu Q.,
RA   Wysocka J., Ye Y., Khochbin S., Ren B., Zhao Y.;
RT   "Identification of 67 histone marks and histone lysine crotonylation
RT   as a new type of histone modification.";
RL   Cell 146:1016-1028(2011).
RN   [9]
RP   SUCCINYLATION AT LYS-121.
RX   PubMed=22389435; DOI=10.1074/mcp.M111.015875;
RA   Xie Z., Dai J., Dai L., Tan M., Cheng Z., Wu Y., Boeke J.D., Zhao Y.;
RT   "Lysine succinylation and lysine malonylation in histones.";
RL   Mol. Cell. Proteomics 11:100-107(2012).
RN   [10]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-13; LYS-21; LYS-24; LYS-25; LYS-35;
RP   LYS-44; LYS-47; LYS-58; LYS-86; LYS-109; LYS-117 AND LYS-121.
RX   PubMed=24681537; DOI=10.1038/nchembio.1497;
RA   Dai L., Peng C., Montellier E., Lu Z., Chen Y., Ishii H.,
RA   Debernardi A., Buchou T., Rousseaux S., Jin F., Sabari B.R., Deng Z.,
RA   Allis C.D., Ren B., Khochbin S., Zhao Y.;
RT   "Lysine 2-hydroxyisobutyrylation is a widely distributed active
RT   histone mark.";
RL   Nat. Chem. Biol. 10:365-370(2014).
RN   [11]
RP   HYDROXYBUTYRYLATION AT LYS-6; LYS-12; LYS-21; LYS-35; LYS-109 AND
RP   LYS-117.
RX   PubMed=27105115; DOI=10.1016/j.molcel.2016.03.036;
RA   Xie Z., Zhang D., Chung D., Tang Z., Huang H., Dai L., Qi S., Li J.,
RA   Colak G., Chen Y., Xia C., Peng C., Ruan H., Kirkey M., Wang D.,
RA   Jensen L.M., Kwon O.K., Lee S., Pletcher S.D., Tan M., Lombard D.B.,
RA   White K.P., Zhao H., Li J., Roeder R.G., Yang X., Zhao Y.;
RT   "Metabolic regulation of gene expression by histone lysine beta-
RT   hydroxybutyrylation.";
RL   Mol. Cell 62:194-206(2016).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and
CC       compact DNA into chromatin, limiting DNA accessibility to the
CC       cellular machineries which require DNA as a template. Histones
CC       thereby play a central role in transcription regulation, DNA
CC       repair, DNA replication and chromosomal stability. DNA
CC       accessibility is regulated via a complex set of post-translational
CC       modifications of histones, also called histone code, and
CC       nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two
CC       molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4
CC       heterotetramer and two H2A-H2B heterodimers. The octamer wraps
CC       approximately 147 bp of DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Monoubiquitination at Lys-35 (H2BK34Ub) by the MSL1/MSL2
CC       dimer is required for histone H3 'Lys-4' (H3K4me) and 'Lys-79'
CC       (H3K79me) methylation and transcription activation at specific
CC       gene loci, such as HOXA9 and MEIS1 loci. Similarly,
CC       monoubiquitination at Lys-121 (H2BK120Ub) by the RNF20/40 complex
CC       gives a specific tag for epigenetic transcriptional activation and
CC       is also prerequisite for histone H3 'Lys-4' and 'Lys-79'
CC       methylation. It also functions cooperatively with the FACT dimer
CC       to stimulate elongation by RNA polymerase II. H2BK120Ub also acts
CC       as a regulator of mRNA splicing: deubiquitination by USP49 is
CC       required for efficient cotranscriptional splicing of a large set
CC       of exons (By similarity). {ECO:0000250|UniProtKB:P33778}.
CC   -!- PTM: Phosphorylated on Ser-15 (H2BS14ph) by STK4/MST1 during
CC       apoptosis; which facilitates apoptotic chromatin condensation.
CC       Also phosphorylated on Ser-15 in response to DNA double strand
CC       breaks (DSBs), and in correlation with somatic hypermutation and
CC       immunoglobulin class-switch recombination. Phosphorylation at Ser-
CC       37 (H2BS36ph) by AMPK in response to stress promotes
CC       transcription. {ECO:0000269|PubMed:15197225,
CC       ECO:0000269|PubMed:16039583, ECO:0000269|PubMed:20647423}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ
CC       cells and marks testis-specific genes in post-meiotic cells,
CC       including X-linked genes that escape sex chromosome inactivation
CC       in haploid cells. Crotonylation marks active promoters and
CC       enhancers and confers resistance to transcriptional repressors. It
CC       is also associated with post-meiotically activated genes on
CC       autosomes. {ECO:0000269|PubMed:21925322}.
CC   -!- PTM: Hydroxybutyrylation of histones is induced by starvation.
CC       {ECO:0000269|PubMed:27105115}.
CC   -!- SIMILARITY: Belongs to the histone H2B family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   -----------------------------------------------------------------------
DR   EMBL; U62673; AAB04769.1; -; Genomic_DNA.
DR   EMBL; AY158940; AAO06250.1; -; Genomic_DNA.
DR   EMBL; AK078533; BAC37326.1; -; mRNA.
DR   EMBL; AK090189; BAC41128.1; -; mRNA.
DR   EMBL; AK143398; BAE25363.1; -; mRNA.
DR   EMBL; AK162494; BAE36945.1; -; mRNA.
DR   EMBL; AK167546; BAE39612.1; -; mRNA.
DR   EMBL; AK168767; BAE40603.1; -; mRNA.
DR   EMBL; AK170749; BAE42000.1; -; mRNA.
DR   EMBL; BC047137; AAH47137.1; -; mRNA.
DR   CCDS; CCDS17635.1; -.
DR   RefSeq; NP_835586.2; NM_178214.4.
DR   UniGene; Mm.439791; -.
DR   ProteinModelPortal; Q64524; -.
DR   SMR; Q64524; -.
DR   BioGrid; 235109; 6.
DR   STRING; 10090.ENSMUSP00000088287; -.
DR   iPTMnet; Q64524; -.
DR   PhosphoSitePlus; Q64524; -.
DR   MaxQB; Q64524; -.
DR   PaxDb; Q64524; -.
DR   PeptideAtlas; Q64524; -.
DR   PRIDE; Q64524; -.
DR   Ensembl; ENSMUST00000090781; ENSMUSP00000088287; ENSMUSG00000068854.
DR   GeneID; 319190; -.
DR   KEGG; mmu:319190; -.
DR   UCSC; uc008qmj.1; mouse.
DR   CTD; 8349; -.
DR   MGI; MGI:2448415; Hist2h2be.
DR   eggNOG; KOG1744; Eukaryota.
DR   eggNOG; ENOG4111NV5; LUCA.
DR   GeneTree; ENSGT00760000118976; -.
DR   HOGENOM; HOG000231213; -.
DR   HOVERGEN; HBG007774; -.
DR   InParanoid; Q64524; -.
DR   KO; K11252; -.
DR   OMA; RETYAVY; -.
DR   OrthoDB; EOG091G0XGD; -.
DR   PhylomeDB; Q64524; -.
DR   TreeFam; TF300212; -.
DR   Reactome; R-MMU-171306; Packaging Of Telomere Ends.
DR   Reactome; R-MMU-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-MMU-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-MMU-2299718; Condensation of Prophase Chromosomes.
DR   Reactome; R-MMU-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-MMU-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-MMU-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-MMU-3214815; HDACs deacetylate histones.
DR   Reactome; R-MMU-3214847; HATs acetylate histones.
DR   Reactome; R-MMU-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-MMU-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-MMU-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-MMU-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-MMU-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-MMU-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-MMU-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-MMU-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-MMU-69473; G2/M DNA damage checkpoint.
DR   Reactome; R-MMU-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-MMU-73777; RNA Polymerase I Chain Elongation.
DR   Reactome; R-MMU-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-MMU-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-MMU-9018519; Estrogen-dependent gene expression.
DR   PRO; PR:Q64524; -.
DR   Proteomes; UP000000589; Chromosome 3.
DR   Bgee; ENSMUSG00000068854; Expressed in 231 organ(s), highest expression level in olfactory epithelium.
DR   CleanEx; MM_HIST2H2BE; -.
DR   Genevisible; Q64524; MM.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005615; C:extracellular space; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0001530; F:lipopolysaccharide binding; ISO:MGI.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0019731; P:antibacterial humoral response; ISO:MGI.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; ISO:MGI.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; ISO:MGI.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; ISO:MGI.
DR   GO; GO:0002227; P:innate immune response in mucosa; ISO:MGI.
DR   GO; GO:0031640; P:killing of cells of other organism; ISO:MGI.
DR   GO; GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; ISO:MGI.
DR   GO; GO:0006334; P:nucleosome assembly; IBA:GO_Central.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000558; Histone_H2B.
DR   PANTHER; PTHR23428; PTHR23428; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00621; HISTONEH2B.
DR   SMART; SM00427; H2B; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00357; HISTONE_H2B; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromosome; Complete proteome; DNA-binding;
KW   Hydroxylation; Isopeptide bond; Methylation; Nucleosome core; Nucleus;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P23527}.
FT   CHAIN         2    126       Histone H2B type 2-E.
FT                                /FTId=PRO_0000244836.
FT   MOD_RES       2      2       N-acetylproline.
FT                                {ECO:0000250|UniProtKB:P23527}.
FT   MOD_RES       6      6       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES       6      6       N6-(beta-hydroxybutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:27105115}.
FT   MOD_RES       6      6       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q16778}.
FT   MOD_RES       6      6       N6-butyryllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P33778}.
FT   MOD_RES       6      6       N6-crotonyllysine; alternate.
FT                                {ECO:0000269|PubMed:21925322}.
FT   MOD_RES      12     12       N6-(beta-hydroxybutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:27105115}.
FT   MOD_RES      12     12       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q16778}.
FT   MOD_RES      12     12       N6-crotonyllysine; alternate.
FT                                {ECO:0000269|PubMed:21925322}.
FT   MOD_RES      13     13       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      13     13       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q16778}.
FT   MOD_RES      13     13       N6-crotonyllysine; alternate.
FT                                {ECO:0000269|PubMed:21925322}.
FT   MOD_RES      15     15       Phosphoserine; by STK4/MST1.
FT                                {ECO:0000269|PubMed:15197225,
FT                                ECO:0000269|PubMed:16039583}.
FT   MOD_RES      16     16       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q16778}.
FT   MOD_RES      16     16       N6-crotonyllysine; alternate.
FT                                {ECO:0000269|PubMed:21925322}.
FT   MOD_RES      17     17       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q16778}.
FT   MOD_RES      17     17       N6-crotonyllysine; alternate.
FT                                {ECO:0000269|PubMed:21925322}.
FT   MOD_RES      21     21       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      21     21       N6-(beta-hydroxybutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:27105115}.
FT   MOD_RES      21     21       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q16778}.
FT   MOD_RES      21     21       N6-butyryllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P33778}.
FT   MOD_RES      21     21       N6-crotonyllysine; alternate.
FT                                {ECO:0000269|PubMed:21925322}.
FT   MOD_RES      24     24       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      24     24       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P33778}.
FT   MOD_RES      24     24       N6-crotonyllysine; alternate.
FT                                {ECO:0000269|PubMed:21925322}.
FT   MOD_RES      25     25       N6-(2-hydroxyisobutyryl)lysine.
FT                                {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      35     35       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      35     35       N6-(beta-hydroxybutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:27105115}.
FT   MOD_RES      35     35       N6-crotonyllysine; alternate.
FT                                {ECO:0000269|PubMed:21925322}.
FT   MOD_RES      35     35       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q16778}.
FT   MOD_RES      37     37       Phosphoserine; by AMPK.
FT                                {ECO:0000269|PubMed:20647423}.
FT   MOD_RES      44     44       N6-(2-hydroxyisobutyryl)lysine.
FT                                {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      47     47       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      47     47       N6-methyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q16778}.
FT   MOD_RES      58     58       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q16778}.
FT   MOD_RES      58     58       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      80     80       Dimethylated arginine.
FT                                {ECO:0000250|UniProtKB:Q96A08}.
FT   MOD_RES      86     86       N6,N6,N6-trimethyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q96A08}.
FT   MOD_RES      86     86       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES      86     86       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q96A08}.
FT   MOD_RES      87     87       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q96A08}.
FT   MOD_RES      93     93       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q96A08}.
FT   MOD_RES     109    109       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES     109    109       N6-(beta-hydroxybutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:27105115}.
FT   MOD_RES     109    109       N6-methyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q16778}.
FT   MOD_RES     116    116       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q00729}.
FT   MOD_RES     117    117       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES     117    117       N6-(beta-hydroxybutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:27105115}.
FT   MOD_RES     117    117       N6-methylated lysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q00729}.
FT   MOD_RES     117    117       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q16778}.
FT   MOD_RES     121    121       N6-(2-hydroxyisobutyryl)lysine;
FT                                alternate. {ECO:0000269|PubMed:24681537}.
FT   MOD_RES     121    121       N6-succinyllysine; alternate.
FT                                {ECO:0000269|PubMed:22389435}.
FT   CROSSLNK      6      6       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate.
FT                                {ECO:0000250|UniProtKB:P58876}.
FT   CROSSLNK     21     21       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate.
FT                                {ECO:0000250|UniProtKB:Q5QNW6}.
FT   CROSSLNK     35     35       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin);
FT                                alternate.
FT                                {ECO:0000250|UniProtKB:Q16778}.
FT   CROSSLNK    121    121       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin);
FT                                alternate.
FT                                {ECO:0000250|UniProtKB:Q16778}.
SQ   SEQUENCE   126 AA;  13993 MW;  1448CB31A490A447 CRC64;
     MPELAKSAPA PKKGSKKAVT KAQKKDGKKR KRSRKESYSI YVYKVLKQVH PDTGISSKAM
     GIMNSFVNDI FERIANEASR LAHYNKRSTI TSREIQTSVR LLLPGELAKH AVSEGTKAVT
     KYTSAK
//
